📑AGAR CROMOGENO P/DETECCION DE MRSA. IMIPENEM MAS EDRA = E TEST. PROCALCITONINA (SEMI CUANTITATIVA)
Procurement process summary
This process is to purchase Agar cromogeno p/deteccion de mrsa. imipenem mas edra = e test. procalcitonina (semi cuantitativa).
This contract was awarded by 🇺🇾 NO VIGENTE Hospital Maciel for an amount of UYU 11,040 to 1 supplier. It was published on 2004-06-29 through open
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
Buying entity🇺🇾 NO VIGENTE Hospital Maciel Buying unitnot reported Publication date2004-06-29 Contest statusnot reported DescriptionCompra Directa 617/2004Awards
This award was granted to ZIGEL LIMITADA by NO VIGENTE Hospital Maciel for an amount of UYU 11,040. The procurement process was conducted through open for the category of Not available. The award was granted on 2004-06-29.
| Supplier | Amount | Award date |
|---|---|---|
| 🇺🇾 ZIGEL LIMITADA | UYU 11,040 | 2004-06-29 |
Market context and opportunities
The execution of this contract allows the entity NO VIGENTE Hospital Maciel to fulfill its public service objectives efficiently.
The open purchase modality ensures that the process is transparent and compliant with regulations.
Transparency in this process is reflected in the detailed publication of all aspects of the contract and its results.
This transparency in public procurement promotes fair competition, prevents corruption, and ensures that public resources are used efficiently for the benefit of citizens.
Additional data
Contract NumberUY_ocds-yfs5dr-a52083-R-213381630018Publication date2004-06-29Contract datenot reportedAward date2004-06-29Categoriesnot reportedPurchase modalityopenMethod detailsCompra DirectaStatusnot reportedData sources
Sociedad.info publishes data from official sources, in compliance with public information access laws. Public access to this data is a civic right that helps hold government accountable. This data, including names and identifiers, is already public in the official source. Read our privacy policy.
